Monic(Roengvoraphoj)DrescherMD

Oncology • Lebanon, NH

Hematologic Oncology

Instructor, Medicine, Geisel School of Medicine

Join to view full profile

Dr. Drescher is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Drescher's full profile

Already have an account?

Office
1 Medical Center Dr
Dhmc- Department Of Hematology/Oncology
Lebanon, NH 03756
Phone+1 603-650-6763
Is this information wrong?

Education & Training

Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Hematology and Medical Oncology, 2009 - 2012
Norwalk Hospital/Yale UniversityResidency, Internal Medicine, 2006 - 2009
Medizinische Fakultät Universität zu KölnClass of 2005

Certifications & Licensure

NH State Medical License 2009 - 2025
VT State Medical License 2022 - 2024
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy Start of enrollment: 2017 Jul 14
Active, not recruiting
Phase 3

Publications & Presentations

PubMed

Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trial.
Robert D McBane 2nd, Charles L Loprinzi, Tyler Zemla, Alfonso Tafur, Kristen Sanfilippo, Jane Jijun Liu, David A Garcia, James Heun, Krishna Gundabolu, Adedayo A Oniti...> ;Journal of Thrombosis and Haemostasis. 2024 Mar 25
Acute inflammatory skin reaction during neutrophil recovery after antileukemic therapy.
Monic Roengvoraphoj, Shaofeng Yan, Frederick Lansigan, M. Shane Chapman, Alexey V. Danilov> ;Cutis. 2016 Oct 1
9 citations
All-trans-retinoic acid antagonizes the hedgehog pathway by inducing patched
Alexander M. Busch, Fabrizio Galimberti, Kristen E. Nehls, Monic Roengvoraphoj, David Sekula, Bin Li, Yongli Guo, James DiRenzo, Steven Fiering, Michael J. Spinella, D...> ;Cancer Biology & Therapy. 2014 Feb 4
89 citations
Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: Focus on epidermal growth factor receptor mutation testi...
Monic Roengvoraphoj, Gregory J. Tsongalis, Konstantin H. Dragnev, James R. Rigas> ;Cancer Treatment Reviews. 2013 Dec 1
Transcriptional responses to epigallocatechin-3 gallate in HT 29 colon carcinoma spheroids.
McLoughlin, P., Roengvoraphoj, M., Gissel, C., Hescheler, J., Certa, U., Sachinidis, A.> ;Genes Cells. 2004 Jul
Identification of differentially expressed genes involved in the formation of multicellular tumor spheroids by HT-29 colon carcinoma cells.
Dardousis, K., Voolstra, C., Roengvoraphoj, M., Sekandarzad, A., Mesghenna, S., Winkler, J., Ko, Y., Hescheler, J., Sachinidis, A.> ;Mol Ther. 2007 Jan
Join now to see all

Abstracts/Posters

Perioperative Bridging of Anticoagulation _ Does Protocol Adherence Improve Outcomes?
Monic R. Drescher, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019